Clinical Trials Directory

Trials / Conditions / Relapsing Polychondritis

Relapsing Polychondritis

11 registered clinical trials studyying Relapsing Polychondritis — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingAn Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondriti
NCT06941376
University of PennsylvaniaPhase 2
RecruitingEfficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
NCT06873100
Peking University People's HospitalPhase 1 / Phase 2
UnknownPediatric Relapsing Polychondritis : Diagnosis and Management in a French Retrospective Study
NCT06019221
University Hospital, Strasbourg, France—
TerminatedBiologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vas
NCT05168475
Cambridge University Hospitals NHS Foundation TrustPhase 2
RecruitingLongitudinal Study for Relapsing Polychondritis
NCT04919538
University of Pennsylvania—
CompletedLow-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis
NCT04077736
Peking University People's HospitalPhase 2
UnknownPatientSpot Formerly Known as ArthritisPower
NCT03840928
Global Healthy Living Foundation—
RecruitingStudies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)—
CompletedStudy on the Safety of Abatacept in Relapsing Polychondritis
NCT01272856
Benaroya Research InstitutePhase 1
WithdrawnTocilizumab for Relapsing Polychondritis
NCT01104480
McMaster Children's HospitalPhase 2
CompletedSingle Patient Study to Treat Relapsing Polychondritis With Tocilizumab
NCT01041248
Children's Hospital of Eastern OntarioN/A